The current patent is useful for parties interested in generation of keratinocytes from embryonic stem cells. The patent covers the induction of differentiation of embryonic stem cells into keratinocytes through exposure of embryonic stem cells to various extracellular matrices obtained from a mammal. Specific ECM proteins include laminin-5, type IV collage, type I collagen or fibronectins.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.